Status:
COMPLETED
Usability of the Software MacuFix for the Categorization of Metamorphopsia
Lead Sponsor:
Augenheilkunde Lindenthal
Conditions:
Vision Disorders
Eligibility:
All Genders
18+ years
Brief Summary
The usability of a novel test to categorize a distorted visual impression (metamorphopsia) is examined with the questionnaire "SUS"
Detailed Description
Introduction Diseases of the retinal centre (macula) can lead to a distorted visual impression (metamorphopsia). The usability of a novel on-screen test to categorize metamorphopsia is to be examined ...
Eligibility Criteria
Inclusion
- Distorted visual impression in at least one eye, detected with Amsler grid:
- Best-corrected visual acuity (BCVA): at least 20/200; age over 18 years; presence of a declaration of consent to participate in the study
Exclusion
- No distorted visual impression in both eyes; best corrected visual acuity under 0.1; age under 18 years
Key Trial Info
Start Date :
May 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04347564
Start Date
May 4 2020
End Date
September 30 2020
Last Update
May 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Augenheilkunde Lindenthal
Cologne, Germany, 50931